r It is unclear precisely how macromolecules (e.g. endogenous proteins and exogenous immunotherapeutics) access brain tissue from the cerebrospinal fluid (CSF).
Introduction
Extracellular transport of molecules between the cerebrospinal fluid (CSF) and the interstitial fluid (ISF) of the central nervous system (CNS) has long been considered to involve size-dependent diffusional transport in brain extracellular space (ECS) and potentially size-independent convective flow pathways elsewhere (Abbott, 2004; Syková & Nicholson, 2008; Wolak & Thorne, 2013) ; however, it has recently been suggested that a clearance process exists that relies in some part on convective flow through the brain parenchyma (Iliff et al. 2012; Nedergaard, 2013) . Although the precise mechanisms of distribution for endogenous and therapeutic macromolecules between the CSF and brain ISF are not yet fully established, an abundance of physiological evidence has nevertheless indicated that transport in the brain parenchyma is governed by diffusion in the small (40-60 nm (Thorne & Nicholson, 2006) ), tortuous ECS of the neuropil (Fenstermacher & Patlak, 1976; Thorne et al. 2004 ; Thorne & Nicholson, 2006; Syková & Nicholson, 2008; Wolak & Thorne, 2013) . Faster convective or bulk flow occurs in the CSF (Davson & Segal, 1995) and decades-old experimental work has also suggested flow could potentially occur in the perivascular (PV) spaces (PVS), white matter tracts and the subependymal region (Cserr et al. 1977; Szentistványi et al. 1984; Ichimura et al. 1991) . Indeed, there is now great interest regarding the specific mechanisms of distribution and the role of the PVS in fluid and solute exchange in the CNS (Iliff et al. 2012; Xie et al. 2013; Asgari et al. 2016; Jin et al. 2016) .
Brain delivery of substances other than small molecules has so far proven extremely difficult (HammarlundUdenaes et al. 2014) , particularly for biologics with limited-to-negligible permeability at the blood-brain barrier (BBB) (Davson & Segal, 1995; Abbott et al. 2006; Calias et al. 2014) and further transport limitations within the CNS (Syková & Nicholson, 2008; Wolak et al. 2015) . There is a critical unmet need for alternative delivery approaches, including semi-invasive strategies such as administration into the CSF (Papisov et al. 2013) . Delivering biologics (e.g. antibodies) to the CNS via the CSF has been the focus of pre-clinical and early stage clinical work (Thakker et al. 2009; Calias et al. 2014) , although the specific mechanisms of transport and detailed patterns of distribution still remain to be clarified (Wolak & Thorne, 2013) , despite numerous clinical trials testing intrathecal infusions in children and adults (Calias et al. 2014; clinicaltrials.gov) . Although diffusional transport over the large distances required for whole brain delivery from the CSF is probably not possible for all but the smallest species (Wolak & Thorne, 2013; Wolak et al. 2015) , growing evidence suggests the cerebrovascular PVS may offer a unique route for achieving rapid, widespread drug distribution via convective/bulk flow (Lochhead et al. 2015) .
The PVS (Fig. 1 ) is a compartment surrounding both leptomeningeal blood vessels and parenchymal blood vessels typically described as being filled with fluid, connective tissue, scattered cells and possibly basement membranes (BM); it is considered to be analogous to the vessel adventitia (Frederickson & Low, 1969; Jones, 1970; Krisch et al. 1984; Zhang et al. 1990; Sixt et al. 2001; Wu et al. 2009 ) and possibly also the BM of the tunica media Weller et al. 2008) . Such a space has been demonstrated in many species, from rodents (Frederickson & Low, 1969) to cats (Jones, 1970) to humans (Zhang et al. 1990 ). The natural dimensions of the rodent PVS appear to be on the order of ß5-10 μm wide at the brain surface (Ichimura et al. 1991; Foley et al. 2012; Iliff et al. 2012) , becoming smaller as the vessel diameter narrows in the parenchyma (Frederickson & Low, 1969) ; the PVS is therefore substantially larger than the brain ECS and has a greater probability of accommodating flow as a result of a much lower hydraulic resistance (Wolak & Thorne, 2013) . The PVS appears to be in communication with the subpial space (Krisch A, the CSF (light blue) of the SAS is contained between the arachnoid mater and pia mater (light purple). Leptomeningeal blood vessels traverse the CSF of the SAS on the surface of the brain; these vessels are covered by a layer of leptomeningeal cells (green), sometimes referred to as the adventitial cell layer. Beneath the pia and its BM (thin grey line) is the subpial space containing connective tissue (e.g. collagen), cells (e.g. macrophages, purple) and subpial vessels. Studies suggest the PVS is continuous between blood vessels in the SAS, the subpial space and the parenchyma (Krisch et al. 1984; Zhang et al. 1990; Ichimura et al. 1991) . Separating the subpial space and PVS from the brain parenchyma is the glia limitans, composed of astrocyte endfeet (light green) and their associated BM (thin grey line). Within the brain parenchyma (inset), cells (neurons in yellow, oligodendrocytes in pink, microglia in light blue, astrocytes in light green) and associated processes (grey) create a narrow and tortuous extracellular space (beige) filled with interstitial fluid (Wolak et al. 1984; Hutchings & Weller, 1986; Ichimura et al. 1991) and possibly also the subarachnoid space (SAS) via fenestrations in the pia mater (Frederickson & Low, 1969; Jones, 1970; Cloyd & Low, 1974; Ichimura et al. 1991) and/or in the leptomeningeal sheaths around subarachnoid blood vessels (Jones, 1970; Cloyd & Low, 1974; Zervas et al. 1982) , although such fenestrations have not been well described for rodents (Frederickson & Low, 1969; Oda & Nakanishi, 1984) . Much evidence suggests that bulk flow occurs in the PVS (Cserr et al. 1977 Rennels et al. 1985; Ichimura et al. 1991; Ghersi-Egea et al. 1996a; Proescholdt et al. 2000; Abbott, 2004; Hadaczek et al. 2006b ), potentially driven by arterial pulsations (Rennels et al. 1985; Hadaczek et al. 2006b; Iliff et al. 2013b) ; indeed, the PVS has been described as a conduit for the rapid influx (Rennels et al. 1985; Iliff et al. 2012) , efflux (Cserr et al. 1977; Szentistványi et al. 1984; Ichimura et al. 1991; Zhang et al. 1992; Carare et al. 2008 ) and possible circulation of a variety of experimentally applied tracer substances (Rennels et al. 1985; Iliff et al. 2012; Nedergaard, 2013) . & Thorne, 2013) . The PVS is surrounded by different components depending on the level, as viewed in cross-section (B-E). B, a leptomeningeal artery on the brain surface has three main layers: the intima [consisting of endothelial cells (pink), endothelial cell BM (dark grey) and the internal elastic lamina (white)], the media [consisting of a few layers of circumferentially arranged smooth muscle cells (pink) and their BM (grey)] and the adventitia [consisting of loose connective tissue (e.g. collagen), scattered cells (e.g. macrophages, purple) and fluid (thus the PV fluid space, darker blue)]. This adventitial space ( * * ) is generally referred to as the subarachnoid PVS and is surrounded by a layer of leptomeningeal cells (green) that separate the blood vessel wall and PVS from the CSF (light blue), with potential points of entry as discussed in the text (e.g. fenestrations or stomata, intercellular clefts and possibly other structures; depicted with arrows). C, a rodent arteriole soon after entering the parenchyma typically has one or two layers of smooth muscle cells and is surrounded by a compartment ( * * ) continuous with the subarachnoid PVS. A layer of pial cells (purple) and their BM (thin grey line) surround the vessel for some distance into the parenchyma, incompletely separating the vessel and fluid space from another fluid compartment continuous with the subpial space ( † †). The vessel and PVS are physically separated from the parenchyma by the glia limitans, which consists of layers of astrocyte endfeet (green) and their BM (grey). D, a capillary in the brain consists of the endothelial cell (pink) and endothelial BM (dark grey) and the pericyte (orange) and pericyte BM (light grey), alongside the astrocyte BM (grey) and astrocyte endfeet (light green). At the level of the capillary, it is unclear whether the endothelial/pericyte BM and astrocyte BM are entirely fused or open to some extent (i.e. with a peri-capillary space) ( * * ), potentially allowing communication along the PVS of the entire vascular tree from arteriole to capillary to venule. E, parenchymal venules (not depicted in A) in the rodent have sparse or no smooth muscle cells and little surrounding pia; thus, the endothelial BM (grey) is directly exposed to the PVS fluid compartment ( * * ). Information compiled from multiple sources (Frederickson & Low, 1969; Jones, 1970; Nabeshima et al. 1975; Zervas et al. 1982; Krisch et al. 1984; Fawcett, 1986; Zhang et al. 1990; Peters et al. 1991) , as well as our own findings. J Physiol 596.3 Pioneering work has long suggested a possible lymphatic role for the PVS (Casley- Smith et al. 1976; Bradbury et al. 1981; Cserr et al. 1981; Yamada et al. 1991; Zhang et al. 1992; Kida et al. 1993) because the brain parenchyma appeared to lack the lymphatic vessels typical of non-CNS tissues (Cserr et al. 1977 Engelhardt et al. 2017) . The PVS also may provide a pathway for cellular migration for the purpose of CNS immune surveillance (Fabry et al. 2008; Ransohoff & Engelhardt, 2012; Engelhardt et al. 2017) . Lastly, the PVS may play some role in CSF/ISF clearance, in addition to drainage pathways along nerves (Faber, 1937; Bradbury & Westrop, 1983; Cserr & Knopf, 1992; Weller et al. 1992; Kida et al. 1993; Koh et al. 2005) and dural lymphatics (Kida et al. 1993; Furukawa et al. 2008; Aspelund et al. 2015; Louveau et al. 2015) to the cervical lymph nodes.
Several unresolved issues remain regarding transport in and around the PVS. First, it is not yet clear what precise anatomical boundaries define where transport can occur (Rennels et al. 1985; Carare et al. 2008) . Second, there is uncertainty over the factors dictating whether peri-capillary transport is possible (Maynard et al. 1957; Jones, 1970; Cervós-Navarro & Ferszt, 1973; Peters et al. 1991) . Third, a lack of consensus is evident regarding the specific sites of PV influx, PV efflux and the potential for PV circulation (Rennels et al. 1985; Zhang et al. 1992; Carare et al. 2008; Iliff et al. 2012) , including the direction of PV flow along arteries vs. veins (Ichimura et al. 1991; Wang & Olbricht, 2011; Coloma et al. 2016; Morris et al. 2016) . Fourth, there has been speculation that a PV circulation involves convective flow through the ECS of the neuropil from peri-arterial to peri-venous spaces that is facilitated by glial aquaporin-4 water channels (the 'glymphatic' hypothesis) (Iliff et al. 2012; Nedergaard, 2013) , although such a flow through the parenchyma has been questioned (Wolak & Thorne, 2013; Hladky & Barrand, 2014; Asgari et al. 2016; Jin et al. 2016) ; indeed, numerous experimental studies have shown transport in brain ECS to be diffusive in nature (Fenstermacher & Patlak, 1976; Thorne et al. 2004; Thorne & Nicholson, 2006; Syková & Nicholson, 2008; Wolak & Thorne, 2013) . Finally, where and how CSF-borne molecules enter the PVS has not yet been clearly addressed. In the present study, we have utilized ex vivo fluorescence and in vivo magnetic resonance imaging (MRI) with intrathecal infusions of well-characterized, non-targeted full-length IgG and single-domain antibody (sdAb) conjugates to address many of these issues. IgG and sdAb span a size range (ß15-150 kDa) that brackets most major endogenous biomolecules, particularly proteins in highest concentration in the CSF (e.g. albumin, IgG) (Davson & Segal, 1995) , as well as proteins with high clinical/therapeutic potential (e.g. lysosomal enzymes, antibody fragments, and full-length antibodies) (Calias et al. 2014) . The results obtained demonstrate that extracellular parenchymal diffusion and PV flow together produce unique size-dependent distribution of antibodies from the CSF to the brain and that PV IgG access can be osmotically manipulated to increase brain distribution.
Methods

Ethical approval
Experiments were carried out at the University of Wisconsin-Madison in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (2011), local Institutional Animal Care and Use Committee regulations, and The Journal of Physiology's guidelines on animal ethics. Rats had access to food and water ad libitum and were housed in a climate-controlled room under a 12:12 h light/dark cycle. All experiments were terminal and every effort was made to minimize the animal's pain and distress.
Intracisternal infusions in rats
Female Sprague-Dawley rats (180-230 g; ß9-14 weeks of age; Harlan/Envigo, Indianapolis, IN, USA) were anaesthetized with urethane (1.3 g kg −1 I.P.) and supplemented (0.375 g kg −1 urethane I.P.) to effect as determined by the absence of a pedal reflex. Body temperature was maintained at 37°C using a homeothermic blanket system (Harvard Apparatus, Holliston, MA, USA). Rats were then tracheotomized, administered 0.05 mL 2% lidocaine hydrochloride S.C. at the scalp for analgesia, and placed in a stereotaxic frame (Stoelting Co., Wood Dale, IL, USA). Atropine sulfate (0.1 mg kg −1 every 2 h) was administered S.C. to diminish bronchial secretions. Rats underwent a dorsal, midline neck incision followed by resection of subcutaneous tissues and posterior vertebral muscles to expose the atlanto-occipital membrane. The atlanto-occipital membrane was then retracted to reveal the dura overlying the cisterna magna for cannula insertion. A custom cannula consisting of 1.5-cm 33-G polyetheretherketone tubing (PEEK; Plastics One Inc., Roanoke, VA, USA) connected via PE-10 tubing (Solomon Scientific, San Antonio, TX, USA) to a Hamilton syringe controlled by an infusion pump (Quintessential Stereotaxic Injector; Stoelting Co.) was filled with infusate prior to insertion. A small hole was created in the dura with a 30-G dental needle (Exel International, Los Angeles, CA, USA) and the PEEK cannula was immediately advanced 1 mm into the cisterna magna, at a 30°angle from the horizontal and with the head approximately in the flat skull position; after insertion, the cannula was carefully fixed in place by cyanoacrylate with the dura tightly sealed around it.
Non-targeted AlexaFluor488 single-domain antibody (sdAb; llama-derived A20.1 V H H antibody fragment against Clostridium difficile toxin, with no known mammalian target; DBS) (Farrington et al. 2014) or AlexaFluor488 goat-anti-rabbit IgG (IgG; A-11034; Invitrogen/Life Technologies, Carlsbad, CA, USA), as characterized in a previous study , was infused intracisternally at 1.6 μL min −1 for 50 min (80 μL total). Following infusion, the abdominal aorta was cannulated with the animal supine, and 50 mL ice-cold 0.01 M PBS (pH 7.4) was perfused at 15 mL min −1 (beginning 30 min post-infusion), euthanizing animals by exsanguination, followed by perfusion with 450 mL 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer. In a subset of animals, 0.5 mL blood was withdrawn 1 min prior to perfusion through the abdominal aorta cannula.
Ex vivo fluorescence imaging
The whole brain, cervical lymph nodes, nasal passages and spinal cord were removed/dissected and imaged immediately using an MVX10 Macroview microscope (Olympus, Tokyo, Japan) equipped with an Orca-flash 2.8 CMOS camera (Hamamatsu, Hamamatsu City, Japan) and a X-Cite 120Q illuminator (Lumen Dynamics Group, Inc., Mississauga, Ontario, Canada) using the appropriate filter set (Chroma, U-M49002XL, Bellows Falls, VT, USA). Whole brains and nasal passages were imaged in two or three overlapping sections and at multiple planes of focus; each section was first autoblended and then overlapping sections were manually aligned and autoblended into a single larger image using Photoshop CC (Adobe Systems, San Jose, CA, USA). After post-fixation in 4% PFA overnight at 4°C, brains were sectioned on a vibratome (100 μm; VT1000S; Leica Microsystems, Wetzlar, Germany) and immediately imaged on a wet petri dish. Lymph nodes and nasal passages were put in 20% sucrose overnight at 4°C, frozen in isopentane on dry ice, sectioned (25 μm) using a cryostat (CM1950; Leica Microsystems) and mounted onto slides [Prolong Gold or Diamond Antifade, with or without 4 ,6-diamidino-2-phenylindole (DAPI); Life Technologies].
Plasma levels
Following intrathecal infusion and just prior to perfusion (79 min) in some animals, 0.5 mL of blood was drawn via cardiac puncture or abdominal aorta cannula, added to a collection tube with heparin, and kept on ice. Blood was spun for 10 min at 3,000 g and the supernatant then spun for 10 min at 10,000 g. The supernatant was removed for fluorescence quantification on a microplate reader (FLUOstar Omega; BMG Labtech, Ortenberg, Germany). Untreated or saline infused animals (N = 6) were used as controls. IgG concentration in plasma was determined by comparison with a standard curve.
MRI
All MRI experiments utilized a 4.7T small animal MRI (Agilent Technologies Inc., Santa Clara, CA, USA) acquired using VnmrJ (Agilent Technologies). After scout scans and optional T2 anatomical scans, isotropic 3D T1-weighted spoiled gradient echo scans were used to detect gadolinium diethylenetriaminepentacetate (Gd-DTPA) labelled bovine IgG (Gd-IgG; Biopal, Worcester, MA, USA) using the sequence parameters: TR = 9.3 ms, TE = 4.7 ms, flip angle = 20°, field of view = 60 × 30 × 30 mm or 70 × 35 × 35 mm, resolution = 256 × 128 × 128, averages = 4, resulting in a scan time of ß10 min 17 s per imaging time point and a voxel size of ß234-273 μm. Animals were prepared identically as described for fluorescence imaging experiments except that, once the cannula was inserted into the cisterna magna and sealed, rats were carefully placed in a transmitting/receiving volume coil in the prone position. Animals were maintained at 37°C using a warm air blower and heart and respiratory rates were monitored to ensure that basic physiological parameters were in the normal range throughout the experiment. A baseline scan was acquired prior to the infusion, after which the subsequent scan and the infusion (1.6 μL min −1 , 80 μL total) were begun simultaneously; animals were then scanned continuously for the remainder of the infusion and typically for a further 1-2 h post-infusion. Animals were then euthanized after the experiment by intracardiac KCl (1 M).
MRI processing
If necessary, registration was performed using a rigid body registration in Matlab (MathWorks Inc., Natick, MA, USA). All additional processing and analysis was performed using Fiji (Schindelin et al. 2012) . Multiple regions of interest (ROIs) were outlined on raw MRI slices to analyse various CSF or brain ROIs (e.g. interpeduncular cistern or striatum) and the average pixel intensity (and other properties, e.g. maximum, minimum and mode) measured for each time point. The percentage change in intensity from the pre-infusion baseline for several areas (depicted in Fig. 2 ) was then averaged across animals; negative values were set to zero. Because Gd-IgG interacts differently with different molecular environments (e.g. CSF vs. grey or white matter), the percentage change from baseline cannot unambiguously be compared between different brain areas (i.e. a 10% increase in signal in a CSF region vs. a parenchymal brain region may not be the result of equivalent increases in Gd-IgG concentration). However, changes within a region and their kinetics are instructive. For 3D dynamic visualization, the pre-infusion baseline image was subtracted from subsequent scans using Fiji (Schindelin et al. 2012) . Negative J Physiol 596.3 values were set to zero and surrounding background tissue signal (e.g. neck muscles) cropped. Baseline-subtracted data was rendered in 4D (3D with time, see Video S1 and S2) using the 3D Viewer plugin (volume, no resampling) (Schmid et al. 2010) . Still images of 3D baseline-subtracted data from individual time points were rendered in the Volume Viewer plugin (Barthel, 2005) using maximum projection mode and trilinear interpolation.
Immunohistochemistry and confocal microscopy
Free-floating 100-μm brain sections (following ex vivo fluorescence imaging) were washed three times in PBS for 5 min, blocked with 3% goat or donkey serum in PBS for 1 h at room temperature and incubated with mouse-anti-rat endothelial cell antigen-1 (RECA-1) primary antibody (ab9774; Abcam, Cambridge, MA, USA; dilution 1:1000) in blocking buffer overnight at 4°C. Sections were next washed in PBS, incubated with goat-anti-mouse AlexaFluor405 (A-31553; Life Technologies; dilution 1:500) or donkey-anti-mouse AlexaFluor 647 (ab150107; Abcam, Cambridge, MA, USA; dilution 1:500) in blocking buffer for 1 h at room temperature, washed again in PBS, and mounted on slides using Prolong Gold or Diamond Antifade (Life Technologies). After secondary incubation, some sections were also incubated with DAPI (Life Technologies; 2 μg mL −1 ) for 20 min at room temperature and then washed in PBS before mounting. Slides were imaged on an FV1000 confocal microscope (Olympus) using FLUOVIEW (Olympus) or an A1R confocal microscope (Nikon, Tokyo, Japan) with NIS Elements (Nikon). For laminin staining, sections were blocked in 1% BSA with 0.5% Triton X-100 for 2 h at room temperature and incubated overnight in laminin γ1 primary antibody (LS; clone D18, 3 μg mL −1 ). Sections were washed in PBS, incubated for 2-3 h at room temperature with secondary antibody (Cy3 goat-anti-mouse, dilution 1:600; 115-165-062; Dianova, Hamburg, Germany), washed in PBS, and mounted for imaging on a LSM 700 confocal microscope (Zeiss, Oberkochen, Germany) using ZEN (Zeiss).
Measurements of extracellular diffusion at the brain section surface following intrathecal infusion
Coronal sections were analysed for diffusion at the brain surface, as previously described . Briefly, images were opened in Fiji (Schindelin et al. 2012 ) and a line (ß80 μm wide and ß500-1200 μm deep) was drawn normal to the brain surface and the fluorescence intensity gradient along the line fitted to the appropriate equations (Paxinos & Watson, 2007) ). For parenchymal brain areas, ROIs were carefully defined, avoiding tissue edges to ensure no contamination from subarachnoid signal. Multiple ROIs were collected for most brain areas, from both hemispheres where applicable, and from both coronal (cor) and sagittal (sag) slices if possible. For each animal, n ROIs were sampled for each of the following areas: olfactory nerves: 5 (3 sag, 2 cor), olfactofrontal cistern: 3 (sag), quadrigeminal cistern: 3 (sag), interpeduncular cistern: 3 (sag), ventral spinal SAS: 3 (sag), cisterna magna: 3 (sag), ambient cistern: 2 (cor), cerebellum (cbm): 3 (sag), trigeminal nerve: 2 (sag); olfactory bulbs (OBs): 6 (4 sag, 2 cor), striatum/caudoputamen (CPu): 6 (4 sag, 2 cor), cortex: 6 (2 sag, 4 cor-2 frontal cortex, 2 somatosensory/motor cortex near bregma), brainstem: 3 (2 sag, 1 cor), hippocampus: 2 (cor), spinal grey matter: 3 (cor). Overall, we sampled from N = 3 animals, so that multiplying the above n yields the total ROIs sampled for a given area (e.g. olfactory nerves, total n = 3 × 5 = 15; spinal grey matter, total n = 3 × 3 = 9). [Colour figure can be viewed at wileyonlinelibrary.com] coronal levels of ß1.5 mm anterior to bregma (±0.5 mm; IgG) or 3 mm posterior to bregma (±1 mm; IgG and sdAb) (Paxinos & Watson, 2007 
Mannitol co-infusion
AlexaFluor 488 goat-anti-rabbit IgG was prepared in 0.27 M or 0.75 M mannitol in 0.01 M PBS (pH 7.4) using Amicon Ultra-0.5 mL centrifugal filters (100 kDa molecular weight cutoff, Millipore, Billerica, MA, USA) for buffer exchange. IgG solution was added to the filter and washed/spun from 0.5 mL three times with 0.27 M or 0.75 M mannitol solution (final osmolality 507-564 mosmol kg −1 and 988-1124 mosmol kg −1 , respectively); each spin was 10 min at 14,000 g. Recovery spin was 2 min at 1000 g. Concentration of IgG protein (absorbance at 280 nm) was measured using a NanoDrop 2000C (Thermo Fisher Scientific Inc., Waltham, MA, USA) before and after filtration, and the protein concentration adjusted after filtration so that animals received identical amounts of IgG, regardless of whether administered in provided buffer or mannitol solution. The lower concentration of mannitol (0.27 M) was chosen because its isomer sorbitol (which is expected to have a similar osmotic effect as mannitol) has been used at this concentration to stabilize adeno-associated virus formulations that have been administered into the CSF (Samaranch et al. 2013 ) and brain (Hadaczek et al. 2006a ) and the higher mannitol concentration (0.75 M) was chosen to be near the upper limit of mannitol solubility at room temperature (Mullin, 2001) . Each of these concentrations was well-tolerated in anaesthetized rats over the duration of the experiment; a previous study has also reported fair tolerability after intracisternal bolus dosing of mannitol in rats (Speck et al. 1988) .
Point source diffusion measurements in free solution and in brain using integrative optical imaging (IOI)
Single-domain antibody diffusion was evaluated in free solution and in the rat neocortex in vivo using IOI, as described previously (Thorne & Nicholson, 2006; Thorne et al. 2008; Wolak et al. 2015) . IOI is a well-characterized method that utilizes epifluorescence microscopy and quantitative image analysis to measure the diffusion of fluorescently-labelled molecules. After a brief pulse injection, successive images of the diffusion cloud were recorded at regular intervals of 1-8 s using a custom program in MatLab (MathWorks Inc.) provided by C. Nicholson and L. Tao (Nicholson & Tao, 1993) . Image analysis was performed using a second MatLab program to fit images with expressions that describe how the 3D clouds resulting from each point source injection project on to the 2D CCD camera according to diffusion theory (Nicholson & Tao, 1993) :
and
where I i is the fluorescence intensity of the ith image at radial distance r from the source point, and E i incorporates the defocused point spread function of the microscope objective. To account for deviation from the point source approximation, a time offset, t 0 , was added to the measured time from injection, t i . Eqn (1) was fit to the upper 90% of the fluorescence intensity curves using a non-linear simplex algorithm, providing estimates of a parameter, γ 2 , at a succession of t i intervals. A linear regression plot of γ 2 /4 vs. t i returned a slope equal to the effective diffusion coefficient (D * ) or free diffusion coefficient (D) based on Eqn (2). Measurements of D were made at 37 ± 1°C using 0.3% NuSieve GTG agarose (Lonza, Basel, Switzerland) in 154 mM NaCl and measurements of D * were at a depth of 200 μm below the pial surface in the primary somatosensory area (barrel field and trunk region) in vivo. D was further used to calculate the apparent hydrodynamic diameter (d H ) using the Stokes-Einstein equation [d H = (kT)/(3πηD), where k is Boltzmann's constant, T is absolute temperature, and η is the viscosity of water (6.9152 × 10 −4 Pa·s at T = 310 K)] ( Thorne et al. 2004) . Diffusion parameters for IgG were taken from a previously published IOI study with the same AlexaFluor488-IgG conjugate as used in the present study.
Perivascular quantification
Quantification of PV profiles and area accessed by intrathecal probes was performed using Fiji (Schindelin et al. J Physiol 596.3 2012), with the general strategy depicted in Fig. 3 . First, the area of each ex vivo fluorescence brain section (in pixels 2 and mm 2 ) was determined by adjusting the threshold to delineate the section boundaries within the image and then by using the wand tool to outline the entire section. Ventricles were excluded from all slice areas. Thresholds were next adjusted until background autofluorescence (typically from white matter) was no longer detectable; thresholds were set equally for all sections within each animal. Three coronal levels were analysed for antibody signal (co-ordinates according to Paxinos & Watson, 2007) : 1.5 mm anterior to bregma (± 1 mm; eight sections per animal), 2.5 mm posterior to bregma (± 1 mm; seven sections per animal) and 5.5 mm posterior to bregma (± 0.25 mm; three or four sections per animal). Next, the slice area was divided into two ROIs, a dorsal portion and ventral portion (a simple division that still allowed us to distinguish some degree of regional heterogeneity). For sections 1.5 mm anterior to bregma, the dorsal/ventral horizontal division line was placed at approximately half the vertical distance from the dorsal-ventral extent of the lateral ventricles (LVs); for sections 2.5 mm posterior to bregma, the horizontal division line was placed just inferior to the dorsal hippocampus and dorsal third ventricle; for sections 5.5 mm posterior to bregma, the horizontal division line was placed just superior to the cerebral aqueduct. The 'analyse particles' command was used to count, characterize and outline PV signal or diffuse surface/white matter signal above the set threshold in each defined dorsal or ventral ROI; no restriction was set on circularity but only profiles greater than two pixels were included (i.e. single pixels were not counted). The number of PV counts per mm 2 slice area was determined by using the raw number of PV counts divided by the total slice area. The number of PV profiles per slice area was not quantified for sdAb because the strong, diffuse surface signal associated with sdAb obscured PV profiles and complicated interpretation.
Scanning electron microscopy (EM)
Rats were anaesthetized with urethane and perfused with ß50 mL ice cold 0.01 M PBS and fixed with ß500 mL 2% PFA and 2.5% glutaraldehyde in 0.1 M phosphate buffer via the abdominal aorta. The brain was removed and certain brain regions carefully dissected. 
using Fiji
A, D and G, first, the ex vivo fluorescence section image was opened in Fiji (sections shown corresponded to IgG infusion). The threshold was then adjusted so that the slice area could easily be selected using the wand tool (shown as yellow outline) and the slice area measured; ventricular or cisternal areas were excluded. B, E and H, second, the threshold for signal was then set for the fluorescence image so that signal could be separated from background (with background set as the level of white matter autofluorescence). Black profiles indicate antibody signal. C, F and I, third, each slice was divided into dorsal and ventral halves, using the following anatomical landmarks for reference: (C) for +1.5 mm sections (eight per animal), the horizontal division line was drawn at approximately half the vertical distance between the dorsal-ventral extent of the LVs; (F) for −2.5 mm sections (seven per animal), the horizontal line was drawn just below the dorsal third ventricles and dorsal hippocampus; and (I) for −5.5 mm sections (three or four per animal), the horizontal line was drawn at the dorsal edge of the cerebral aqueduct. Lastly, after dividing each slice into dorsal and ventral regions, the Fiji command 'analyse particles' was run to count and characterize PV profiles ( Tissue samples were post-fixed overnight in 2% PFA with 2.5% glutaraldehyde at 4°C, and dehydrated in increasing levels of ethanol at room temperature. Tissue was then dried using a CO 2 critical point dryer (Tousimis, Sandri 780A, Rockville, MD, USA) and sputter coated with ß3-5 nm 60:40 gold:palladium using a Auto ConductVac IV (SeeVac, Pittsburgh, PA, USA) prior to imaging (10 kV, 25-10,000X) on an S570 scanning EM (Hitachi, Tokyo, Japan) or LEO 1530 field emission scanning EM (3 kV; Zeiss).
Statistical analysis
A Student's two-tailed t test was used to determine statistical differences for all two-way comparisons (e.g. IgG vs. sdAb), with P values listed in the text. A Kruskal-Wallis one-way ANOVA on ranks (P < 0.001) was performed for group comparisons (e.g. IgG vs. IgG with 0.27 M or 0.75 M mannitol) where at least one group did not pass normality or equal variance tests, followed by post hoc pairwise testing using Dunn's method (unless otherwise specified) with P < 0.05. A one-way analysis of variance was performed (P < 0.001) for one group comparison characterized by normal distribution and equal variance, followed by a Bonferroni post hoc test (P < 0.001). Statistical analyses were performed using SigmaPlot (Systat Software Inc., San Jose, CA, USA). All values are listed as the mean ± SEM (N animals, n measurements).
Results
Whole brain ex vivo fluorescence imaging
We initially characterized antibody probes using IOI diffusion measurements (Nicholson & Tao, 1993; Thorne et al. 2004 Thorne et al. , 2008 , confirming monomeric behaviour and yielding Stokes-Einstein apparent hydrodynamic diameters (d H ) for AlexaFluor488-labelled sdAb (16.8 kDa (Farrington et al. 2014) ; D = 14.7 ± 0.3 × 10 −7 cm 2 s −1
and d H = 4.47 ± 0.11 nm; n = 43) ( Fig. 4 ) and AlexaFluor488-labelled IgG (150 kDa; D = 6.47 × 10 −7 cm 2 s −1 and d H = 10.15 nm; ). Anaesthetized, Sprague-Dawley rats were placed in a stereotaxic frame and a cannula was placed in the cisterna magna. Antibodies were intrathecally infused, with animals in a prone position, for 50 min at a flow rate of 1.6 μL min −1 (approximately half the CSF production rate) (Davson & Segal, 1995) , followed by a post-infusion distribution time of 30 min and then perfusion-fixation; other studies have recently utilized similar infusion site/rates and infusion/post-infusion durations in rats with other intrathecal tracers (Yang et al. 2013; Iliff et al. 2013a; Bedussi et al. 2017) and shown that such a flow rate does not appreciably elevate intracranial pressure (Yang et al. 2013; Bedussi et al. 2017) . Whole brains were removed and ex vivo imaging of the ventral and dorsal brain surfaces demonstrated high PV signal for both sdAb (N = 6) and IgG (N = 10) along cerebral arteries (Fig. 5 ). Antibody signal was apparent, albeit lower, around surface veins (e.g. the caudal rhinal vein) (Fig. 5J and K) . Antibody associated with the PVS of penetrating vessels perpendicular to the brain surface appeared as punctate signal (circled in Fig. 5G ). High signal was particularly prominent at brain-CSF interfaces (e.g. at the olfactofrontal and quadrigeminal cisterns), the olfactory bulbs and around cranial (e.g. II, V, VIII and XII) and spinal nerves . There was a noticeable size-dependent surface distribution; generally, sdAb signal appeared to be brighter and more diffuse, whereas IgG signal appeared to be more restricted to the PVS (e.g. Fig. 5F and G); in addition, diffuse and PV signal on the ventral brain surface appeared to be greater than dorsal signal for both antibodies (Fig. 5A , B, D and E). Saline-infused animals showed relatively low fluorescence ( Fig. 5B and E, insets).
In vivo 3D MRI of intrathecal IgG
In vivo 3D T1-weighted MRI allowed tracking of a Gd-DTPA contrast agent conjugated to full-length IgG (Gd-IgG) over time using the same infusion paradigm and animal positioning as above. Compared to whole brain ex vivo fluorescence, 3D baseline-subtracted T1-weighted image contrast enhancement associated with Gd-IgG signal showed a similar distribution of PV signal along cerebral arteries, as expected ( Fig. 5C and Videos S1 & S2). Representative raw sagittal MRI slices showed high signal in CSF cisterns, particularly ventrally (correlating with ex vivo fluorescence signal), and increasing signal in the brain parenchyma with time ( Fig. 6A-D 
and M-U).
Gd-IgG signal in the SAS was sparse over the dorsal cortex; anatomical T2 scans (not shown) and previous studies suggest this is probably a result of less CSF/SAS in these areas (Pease & Schultz, 1958; Morse & Low, 1972; Oda & Nakanishi, 1984) . The percentage signal change from pre-infusion baseline for several ROIs (Fig. 2) over time yielded strikingly different kinetics (e.g. time to peak change) in CSF ROIs ( Fig. 6E and Table 1 ) vs. parenchymal ROIs (Fig. 6F ). Signal in CSF ROIs tended to increase during the infusion and then fall as (or shortly after) the infusion finished, whereas parenchymal ROIs tended to progressively increase throughout the experiment (even in two animals imaged for greater than 2 h post-infusion). CSF ROIs nearest the infusion site demonstrated a higher peak percentage change from baseline and a lower time to peak change than CSF ROIs further from the infusion site (i.e. the ventral spinal subarachnoid space had a significantly higher peak percentage change compared to all other more rostral CSF cisterns) ( Table 1) . Carefully-selected ROIs within the LVs or fourth ventricle J Physiol 596.3 ( Fig. 6G and H) were also analysed, showing that ventricular Gd-IgG signal increased with time, with a kinetic profile similar to parenchymal ROIs, although the lack of differences between the sampled LV and fourth ventricle ROIs suggest backflow through the ventricular system was not the source of this signal increase (Fig. 6I) . Raw coronal MRI slices at the upper cervical level showed the greatest signal increase (relative to pre-infusion baseline) in the SAS and butterfly-shaped spinal cord grey matter (Fig. 6J, K, T and U) ; greater contrast in the spinal grey vs. white matter corresponded to a dramatically higher vascularity in the spinal grey (Fig. 6L ) and agreed well with markedly higher PV signal seen in that region in ex vivo fluorescence experiments (discussed below). 3D contrast enhancement with time clearly demonstrated a rostrally-directed flow around the brain towards CSF efflux routes such as the olfactory nerves (Video S2). (1)). The data are shown in colour (agarose, red; cortex, orange) to facilitate comparison with the curve fits at each time point (black). C, curve fitting at each point from (A) and (B) returns a parameter, γ 2 /4, that produces a line with a slope equal to D or D * IOI after linear regression on time (data transformed to a zero y-intercept for comparison between molecules). Linear regression fits for sdAb and IgG free diffusion coefficients (continuous lines) and effective diffusion coefficients (dashed lines) obtained in the present study (sdAb; filled circles) and from a previous study 
I
Ex vivo fluorescence imaging of coronal brain sections
Imaging of coronal brain sections revealed striking parenchymal sdAb and IgG distributions of two basic types: (i) hundreds of PV signal profiles in deeper brain regions at a variety of cortical and subcortical locations and (ii) a tight yet observable surface gradient at brain-CSF interfaces ( Fig. 7A-D) . Perivascular signal was evident along the entire neural axis for both sdAb and IgG, with a distribution that was more prominent ventrally (Figs 7A and B and 8) . Antibody distribution was quantified in brain sections using Fiji, yielding a percentage slice area with antibody signal (Fig. 3) . Signal was analysed in dorsal or ventral halves of brain slices at three different coronal levels. A significantly greater percentage area with signal was measured for sdAb than for IgG in both dorsal and ventral regions at all levels (P < 0.001) ( Fig. 7E and Table 2) ; averaging values over the 7-mm rostral-caudal distance sampled, the approximate mean areas accessed by sdAb and IgG were 11.6% and 1.95%, respectively (expressed as a percentage of the total slice area) ( Table 2) . Greater sdAb signal was particularly evident at brain surfaces, within periventricular white matter and in the PVS throughout each slice. Diffuse signal at the brain surface was analysed for sdAb and IgG using Fiji. Fluorescence intensity gradients were extracted along lines perpendicular to the brain surface (Fig. 7F ). The resulting profiles were then fit to the appropriate diffusion equation to assess agreement with diffusion theory (Fig. 7G) and, if so, to estimate a diffusion coefficient in brain after intrathecal infusion (D * infus ). The D * infus was then compared with the effective diffusion coefficient measured in the cortex beneath the brain surface in vivo using the well-established method of IOI (D * IOI ); this allowed us to evaluate whether the antibody surface gradients from intrathecal infusions in a closed system were consistent with parenchymal diffusion in deeper brain measured using open cranial windows and point source intraparenchymal injections with IOI (Fig. 7H) . D * infus for sdAb at the ventral brain surface after intrathecal infusion (D * infus = 32 ± 0.7 × 10 −8 cm 2 s −1 ; n = 32, N = 4) ( Fig. 5N and Video S2) during the 50-min infusion, as well as increasing levels in the parenchyma (e.g. see cortex and striatum) with time. The percentage change in Gd-IgG signal from pre-infusion baseline was quantified in specific CSF (E) or parenchymal brain (F) ROIs (N = 3) (Fig. 2) . G-I, quantification of percentage change from baseline in the LV and fourth ventricle (4V) from MRI. Small, carefully-chosen ROIs (yellow boxes) were selected in the LV (G; ß1.5 mm lateral to the midline) or fourth ventricle (H; approximately at the midline). Gd-IgG signal is evident surrounding the dark vessels of the circle of Willis and the basilar artery, as well as in the subarachnoid space around the spinal cord, where the spinal grey matter has had a noticeable signal increase. O, the dark lumen of the middle cerebral artery is visible pre-infusion as it branches laterally, and is surrounded by Gd-IgG signal (P) ß30 min post-infusion. Q, schematic depicting the approximate location of structures in (M) to (P). R, coronal brain or (T) spinal cord sections before, during and after 50 min of Gd-IgG infusion. Gd-IgG signal is prominent in parenchymal and subarachnoid CSF spaces. S and U, schematics depicting the approximate location of structures in (R) and (T), respectively. Corresponding sections in (Q), (S) and (U) adapted from (Paxinos & Watson, 2007) . different by one-way ANOVA (P < 0.001); pairwise post hoc comparisons using the Holm-Sidak method showed that ventral spinal SAS peak percentage change values were significantly greater than values for the interpeduncular (P = 0.011), ambient (P = 0.002), quadrigeminal (P < 0.001) and olfactofrontal cisterns (P < 0.001) ( a ) and the interpeduncular cistern peak percentage change value was significantly higher than the value for the olfactofrontal cistern (P = 0.04) ( b ).
Ex vivo confocal microscopy of perivascular antibody distribution
Representative sections were chosen for immunohistochemistry and confocal microscopy to examine PV localization. Both sdAb and IgG signal surrounded leptomeningeal surface arteries (endothelial cells immunolabelled with rat endothelial cell antigen-1) in the fluid-and connective tissue-space of the presumed adventitia but sdAb had markedly greater access to the tunica media [i.e. putative BM between smooth muscle cells (α smooth muscle actin+)] compared to IgG ( Fig. 9A and E) . Both antibodies were distributed along parenchymal PVS including putative arteries/arterioles ( Fig. 9B and F; with characteristic circumferential bands of signal associated with the smooth muscle BM), putative veins/venules ( Fig. 9C and G) and microvessels ( Fig. 9D and H, arrow in I; as small as 4 μm in diameter), based on vessel size and morphology. Overall, sdAb had a more continuous distribution within the PVS and a more diffuse signal in the neuropil surrounding the PVS compared to IgG. The antibody signal for both sdAb and IgG was prominent at the brain surface, probably associated with the pia and/or subpial space, and often exhibited a punctate appearance within putative macrophages (Iba1/Cd11b/Lyve-1+) in the SAS and in the PVS (arrowheads in Fig. 9B and F) . The PV signal was consistently prominent around lenticulostriate vessels (Fig. 9I) , where a pan-laminin BM marker demonstrated that IgG co-localized with astrocyte BM and smooth muscle BM but not endothelial BM (Fig. 9I, inset ).
Electron microscopy of potential perivascular entry points on leptomeningeal vessel sheaths
Potential routes of entry from the CSF into the PVS of rodents have received surprisingly little attention, despite their obvious importance and potential to screen or filter CSF-borne macromolecules. We investigated whether stomata, leptomeningeal fenestrations/pores that have been shown on the adventitial cell layer bordering the CSF of surface vessels in the cat (Zervas et al. 1982) , could be demonstrated on the adventitial surface of major leptomeningeal vessels in the rat using scanning EM. Untreated rats were perfused, fixed, and several tissue areas around the anterior cerebral, middle cerebral, basilar and vertebral arteries and the optic, interpeduncular and quadrigeminal cisterns were processed for scanning EM. Careful investigation revealed the presence of numerous stomata on the adventitial surface (i.e. at the site of the green leptomeningeal cells depicted in Fig. 1A and B) of all vessels examined (Fig. 10A-D) , with a strikingly similar appearance to those in the cat (Zervas et al. 1982) . These pore-like structures typically exhibited a uniform, smooth rim, with diameters mostly in the range of 1-3 μm. A dense meshwork of underlying connective tissue, presumably fibrillar collagen, was also clearly visible through the pores Intrathecal sdAb resulted in a large, diffuse surface gradient, particularly on the ventral surface, and numerous PV profiles throughout the section, including deep brain regions (e.g. deep cortex and striatum). sdAb also spread along periventricular white matter ( * ). Intrathecal IgG resulted in a small gradient at the brain surface, as well as widespread PV signal, although far less than sdAb. Fluorescence signal above a certain threshold (shown in black) was detected throughout the entire section area (outlined in red) using Fiji for (C) sdAb and (D) IgG (number of profiles for the representative images shown: sdAb, 1153; IgG, 843). E, the percentage area with antibody signal was then rigorously quantified (Fiji) for dorsal (d) and ventral (v) halves of multiple 100 μm sections, centred at three different bregma levels (+1.5 mm, eight sections per animal; −2.5 mm, seven sections per animal; −5.5 mm, three or four sections per animal), for sdAb [N = 5 animals; e.g. for section shown in (C), dorsal and ventral percent areas were 9.06% and 23.9%, respectively] and IgG [N = 5 or 6 animals; e.g. for section shown in (D), dorsal and ventral percent areas were 1.04% and 2.67%, respectively]. Summary data (symbols indicate individual sections analysed, columns indicate individual animals, and bars indicate the mean ± SEM) showed percentage slice area accessed by the sdAb was significantly greater compared to IgG for all six dorsal and ventral regions examined (P < 0.001). F, surface gradients at the brain-CSF interface along
Enhanced perivascular access of IgG with co-infusion of mannitol
The results showing an inverse correlation between PV access/distribution and probe size suggested a size-dependent filtration process may restrict PV access from the CSF (possibly as a result of sieving by stomata and their associated connective tissue, as described above, or by similar structures present on the pia). We hypothesized that intrathecal co-infusion of an osmolyte might increase the access of the larger IgG to the PVS (e.g. by osmotically drawing water out of leptomeningeal lining cells on the adventitial surface of vessels in the SAS). IgG was prepared in either 0.27 M (5%; N = 6) or 0.75 M mannitol (14%; N = 9) and then infused intrathecally using the same infusion parameters as described above. Ex vivo fluorescence imaging of brain sections and subsequent quantification using Fiji (Fig. 3) indicated that mannitol co-infusion enhanced IgG PV access in a dose-dependent manner ( Fig. 11A-D) , resulting in a significantly increased percentage slice area with IgG signal (Fig. 11E ) and a greater number of PV profiles per mm 2 (Fig. 11F ). Co-infusion with 0.27 M mannitol yielded a significantly increased percentage area accessed by IgG in 4/6 areas sampled (dorsal or ventral halves of brain slices at three different coronal levels, as above) and a significantly increased number of PV counts per mm 2 in three of six areas sampled compared to IgG alone. Co-infusion of IgG with 0.75 M mannitol yielded a significantly increased percentage area and a significantly increased number of PV counts per mm 2 in all areas sampled compared to IgG alone. Co-infusion of IgG with 0.75 M mannitol also resulted in a significantly increased percentage area in 3/6 areas sampled and showed more prominent spread of IgG along periventricular white matter compared to 0.27 M mannitol lines normal to the section surface (yellow) were next assessed for consistency with size-dependent, Fickian diffusion from the CSF into the brain, as described in Wolak et al. (2015) ; lines were analysed at a ventral location for sdAb and at dorsal and ventral locations for IgG (as shown). G, the raw surface gradient data was fit to the diffusion equation to estimate a brain surface diffusion coefficient after intrathecal infusion (D * infus ; data shown: sdAb, D * infus = 3.33 × 10 −7 cm 2 s −1 ; IgG dorsal, D * infus = 0.23 × 10 −7 cm 2 s −1 ; IgG ventral, D * infus = 0.34 × 10 −7 cm 2 s −1 ). H, summary data (mean ± SEM) for parenchymal diffusion measurements from intrathecal surface gradient profiles (D * infus ) or from point source injections in the somatosensory cortex using integrative optical imaging (D * IOI ) (for details, see Fig. 4 ). Differences between sdAb D * infus (N = 4 animals, n = 30 measurements) and D * IOI (N = 4, n = 19) were not significant (n.s.; P = 0.62). However, dorsal IgG D * infus (N = 5, n = 34) was significantly lower than ventral IgG D * infus (N = 5, n = 50) and both IgG D * infus were significantly lower than IgG D * IOI ; value reported in Wolak et al. (2015) . Sagittal schematic adapted from (Swanson, 1998) ; scale bars = 1 mm. Widespread PV signal was evident from the most anterior sections (e.g. olfactory bulb) to the most posterior sections examined (e.g. cerebellum and brainstem). Section levels are indicated to denote the approximate coronal levels anterior or posterior to bregma, according to Paxinos & Watson (2007) . Choroid plexus-associated signal was evident in all ventricles for sdAb infusions and for infusions of IgG only when co-infused with mannitol (dose-dependent). Note that PV signal in the cortex exhibited more variability than most other brain areas. See text for additional details. Scale bars = 1 mm. Antibody signal above a background threshold was quantified using Fiji to measure the percentage area with antibody signal within dorsal or ventral halves of brain slices (1.5 mm anterior or 2.5 mm and 5.5 mm posterior to bregma) and the number of PV profiles normalized by slice area (mm 2 ). Values represent the mean ± SEM; N animal experiments and n brain sections per treatment group.
co-infusions, confirming mannitol dose-dependence. In summary, co-infusion with 0.75 M mannitol dramatically increased the brain area accessed by IgG by ß93% and increased the number of PV profiles per slice area by 1.46-fold compared to IgG alone (Table 2) . Mannitol co-infusion also markedly increased PV access of IgG in the spinal grey matter (Fig. 11G-I ). Confocal imaging demonstrated that mannitol co-infusion increased IgG access to the innermost smooth muscle BM layers of large leptomeningeal arteries (Fig. 11J-M ) and allowed more continuous PV distribution along penetrating vessels. Co-infusion of 0.75 M mannitol did not appreciably alter the distribution of the smaller sdAb (data not shown), suggesting that mannitol elicited increased PV access in a size-dependent fashion.
CSF drainage routes
Intrathecal infusions of both sdAb and IgG resulted in high signal in the olfactory mucosa and deep cervical lymph nodes (Fig. 12) , along CSF efflux routes that have been previously identified in many other studies (Faber, 1937; Bradbury et al. 1981; Bradbury & Westrop, 1983; Szentistványi et al. 1984; Zhang et al. 1992; Kida et al. 1993; Koh et al. 2005) , although nasally-directed CSF efflux has recently been called into question (Louveau et al. 2015) . Within the nasal passages, most of the antibody signal was localized to the olfactory mucosa and cribriform plate (Fig. 12A-D) ; confocal microscopy of olfactory mucosa coronal cryosections demonstrated that IgG signal was present throughout the lamina propria where it surrounded putative blood vessels, lymphatic vessels and nerve bundles, with signal stopping abruptly at the basal lamina ( Fig. 12E-I ). Antibody drainage to the deep cervical lymph nodes (consistent with much past work (Bradbury et al. 1981; Bradbury & Westrop, 1983; Szentistványi et al. 1984) ) was indicated by prominent signal in all animals intrathecally administered either sdAb or IgG (Fig. 12A and B inset) and all animals receiving IgG with either 0.27 M mannitol or 0.75 M mannitol. Often, at least one superficial cervical lymph node exhibited signal (consistent with past work; Szentistványi et al. 1984) although, when present, it always appeared of lower intensity than the deep cervical lymph node signal. IgG signal was also noticeably present around nerves [e.g. the nerve layer of the olfactory bulb surface, the optic,
trigeminal and hypoglossal nerves (Fig. 5A, B and F-I) , and spinal nerves ( Fig. 5L) ], possibly associated with cranial and spinal nerve-associated efflux routes (Faber, 1937; Bradbury & Westrop, 1983; Cserr & Knopf, 1992; Weller et al. 1992; Kida et al. 1993; Koh et al. 2005) and clearance along dural lymphatic vessels (Aspelund et al. 2015) . Clearance of IgG to the plasma compartment 30 min post-infusion, presumably via arachnoid villi and lymphatic drainage routes, resulted in low plasma concentrations: 26.8 ± 1.3 nM after intrathecal IgG (N = 9); 28.6 ± 1.7 nM after co-infusion of IgG with 0.27 M mannitol (N = 5); and 35.1 ± 0.85 nM after co-infusion of IgG with 0.75 M mannitol (N = 9). Although 0.75 M mannitol co-infusion yielded a small yet significant elevation in plasma IgG concentration compared to IgG alone and 0.27 M mannitol co-infusion, these levels were orders of magnitude below the infused IgG concentration (13 μM) and the low μM CSF levels probably resulting from the infusion after taking into account CSF dilution.
Discussion
The major findings of the present study are: (i) fluorescence intensity gradients within the neuropil at the brain surface were consistent with diffusive transport and exhibited clear antibody size-dependence; (ii) sdAb and IgG each appeared to distribute perivascularly to some degree along all vessel types studied (i.e. arteries, arterioles, microvessels, venules and veins); (iii) the percentage brain area accessed was strikingly greater for the smaller sdAb than for the larger IgG; (iv) PV access to the smooth muscle BM of the tunica media exhibited size-dependence; (v) intrathecal co-infusion of an osmolyte, mannitol, markedly increased access of IgG to PV compartments in a dose-dependent manner; and (vi) CNS clearance of antibodies was prominent along olfactory pathways to the olfactory mucosa and cervical lymph nodes. Finally, scanning EM revealed numerous leptomeningeal vessel stomata (micron-sized pores on the CSF-facing outer surface cell layer of the vessels; not to be confused (Fig. 1B) . The smaller sdAb (A) distributed throughout the outer connective tissue space ( * * ) and the tunica media ( * ). E, IgG distributed throughout the outer connective tissue PVS, although penetration of the tunica media appeared restricted. Representative images of putative penetrating cortical arterioles showed sdAb (B) and IgG (F) distributed along the pial surface and around the borders of circumferentially arranged smooth muscle cells (presumably in the BM). Punctate sdAb and IgG signal was present in subarachnoid cells at the cortical surface (e.g. macrophages, arrowheads). Antibody signal was also present longitudinally along many vessels (likely in association with PV collagen). Based on size and morphology, sdAb and IgG were also found to be present in the PVS of numerous putative venules (C and G; representative examples) and microvessels (D and H; representative examples); often, a line of antibody signal could be seen extending away from microvessels, likely due to BM extending into the ECS between astrocytic endfeet (Peters et al. 1991) . I, IgG association with PV/vascular BM (endothelial, smooth muscle and astrocyte) was revealed by laminin γ 1 (pan-laminin) staining. An arteriole in the striatum demonstrated a particularly large, presumably fluid-filled PVS compartment ( * ), although its exaggerated size and lack of IgG signal was probably a result of tissue processing and washout; co-localization of IgG with the astrocyte BM and smooth muscle BM of the arterial wall (and other fixable elements) was noticeably evident. A longitudinal cross-section (inset; scale bar = 50 μm) revealed that IgG did not extend as far as the innermost endothelial BM because no co-localization was evident (e, endothelial cell; e BM, endothelial BM; a BM, astrocyte BM; SM, smooth muscle cell; SM BM, smooth muscle BM). IgG was also visible around microvessels (arrows) and a few, scattered brain cells in nearby regions (arrowheads).
with the inner surface endothelial cell layer) in rodents. We speculate that these unique fenestrations may play a role in the size-dependent PVS access of CSF-borne macromolecules. Our results provide strong support for two principal mechanisms governing transport of antibodies from CSF to brain: diffusion from the CSF into the ECS at the brain surface and convection in the PVS of cerebral blood vessels to deep brain regions.
Diffusion in the extracellular space of the neuropil
Recent intracisternal infusion studies in mice (Iliff et al. 2012; Xie et al. 2013 ) and rats (Yang et al. 2013; Iliff et al. 2013a ) have led to speculation that aquaporin-4 water channels on astrocyte endfeet allow a convective flux or flow of CSF/ISF through the parenchymal ECS, facilitating convective transport of various tracer substances along brain-wide pathways (termed 'glymphatic' because of a proposed reliance on glia and role in lymphatic-like brain drainage) out of the arterial PVS through the brain ECS and into the PVS of veins for clearance (Nedergaard, 2013) . However, the occurrence of convective flow through the ECS of the neuropil has been called into question based on theoretical considerations and modelling results that suggest diffusion to be a more plausible mechanism (Wolak & Thorne, 2013; Asgari et al. 2016; Jin et al. 2016) . Our experimental results, employing the same infusion site/rate and similar infusion/post-infusion durations as those used with other tracers in the experimental work underlying the 'glymphatic' concept (Yang et al. 2013; Iliff et al. 2013a) , provide further evidence indicating that diffusion, and not convection, is likely to be the predominant transport process governing distribution in the ECS of the neuropil. Fluorescence intensity brain surface gradients from intrathecal infusions were extracted from different coronal sections several millimetres apart and the resulting profiles fit with the appropriate one-dimensional solution to the diffusion equation , similar to an older approach pioneered by Fenstermacher and colleagues with radiotracer perfusions (reviewed in Syková & Nicholson, 2008; Wolak & Thorne, 2013) . The excellent fit of these profiles strongly suggests diffusive transport as the dominant transport mechanism at least 200 μm (IgG) to 800 μm (sdAb) deep into the brain surface from the CSF. Furthermore, the sdAb effective diffusion coefficient obtained from the ventral brain surface profiles after intrathecal infusion was almost identical to that obtained using the IOI method, where intraparenchymal injections were performed in somatosensory cortex at a depth of 200 μm in separate animals. . The reasons for this are not entirely clear, although we speculate that the environment for IgG diffusion into the brain across the pial surface may exhibit subtle differences from the parenchyma several hundred microns below, in that structural complexity associated with the extensive surface glia limitans (Ghersi-Egea et al. 1996a; Fenstermacher et al. 1997) (Table 2) . Sagittal schematic adapted from (Swanson, 1998) . G-I, ex vivo fluorescence of upper cervical spinal cord cross-sections (scale bars = 0.5 mm). PV IgG signal was predominantly in the spinal grey matter following infusion of IgG alone (G) and exhibited a dose-dependent increase with co-infusion of (H) 0.27 M mannitol or (I) or 0.75 M mannitol. J-M, confocal microscopy of the wall of the (leptomeningeal) internal carotid artery after antibody infusion (infused antibody, green), stained for rat endothelial cell antigen-1 (RECA-1) to indicate the vascular endothelial cell layer associated with the tunica intima (blue). J, sdAb distributed in the outer connective tissue space ( * * ) and throughout the entire tunica media ( * ) in the smooth muscle basement membrane, although (K) IgG was essentially absent from this layer. L, co-infusion of 0.27 M mannitol slightly increased IgG access and (M) co-infusion of 0.75 M mannitol often substantially increased IgG access to the smooth muscle layer, sometimes to a level of appearance similar to that exhibited by sdAb (J).
and/or site-dependent differences in astrocytic expression of Fcγ receptors (Okun et al. 2010 ) may result in a greater sieving of IgG and/or more pronounced IgG hindrance because of rapid, reversible Fc binding; size-dependent diffusional hindrance and reduced effective diffusion as a result of binding in the brain have been demonstrated previously (Thorne & Nicholson, 2006; Thorne et al. 2008) . We did observe differences in the relative signal intensities associated with brain surface profiles (and their apparent depth of penetration) across different sites, although such differences should not affect the calculated diffusion coefficient. CSF antibody levels probably varied at different brain-CSF interfaces; indeed, MRI appeared to demonstrate greater exposure of ventral brain regions to Gd-IgG in the CSF, with little CSF (as seen by T2 MRI) or Gd-IgG contrast over the dorsal brain region. Lastly, distributions often exhibited many profiles consistent with concentration gradient-driven radial diffusion out from the PVS of parenchymal vessels, particularly microvessels (Fig. 9D) ; similar radial profiles around parenchymal vessels have been observed in other studies, such as following intraventricular acid sphingomyelinase or intracisternal adeno-associated virus infusions in macaques (Ziegler et al. 2011; Samaranch et al. 2013) . Recently, it was suggested that the brain ECS volume in mice is reduced during the awake state compared to during sleep or under ketamine/xylazine anaesthesia (Xie et al. 2013) and so it remains possible that certain aspects of our results may have been different (e.g. more limited brain surface profiles because of hindered extracellular diffusion resulting from reduced ECS width; Thorne & Nicholson, 2006) had the experiments been conducted in awake rats rather than the urethane-anaesthetized animals utilized in the present study. This possibility awaits further study along with replication of the awake brain ECS volume reduction finding (Xie et al. 2013) by other laboratories and in other species such as the rat. Importantly, urethane anaesthesia has been shown to cause only modest effects on both excitatory and inhibitory neurotransmission compared to other anaesthetics (e.g. isoflurane, ketamine; Hara & Harris, 2002) and to induce a sleep-like state in rodents (Clement et al. 2008) and so it may also be useful to carefully evaluate diffusion and PV transport in future studies by comparing intrathecal tracer distributions using different anaesthetics. Our results were generally consistent with other studies where a variety of non-antibody tracer substances, such as horseradish peroxidase, ovalbumin, and small and large molecular weight dextrans, have been infused into the CSF of rodents, cats and dogs (Wagner et al. 1974; Rennels et al. 1985; Iliff et al. 2012 Iliff et al. , 2013a Xie et al. 2013) . Although a previous rat study (Iliff et al. 2013a) compared the intrathecal distribution of two gadolinium non-dextran contrast agents with fluorescent dextran tracers in three parenchymal CNS areas of the rat, the present study is the first to correlate findings across MRI and ex vivo fluorescence imaging using a single physiologically and therapeutically relevant protein, IgG, with a much expanded list of parenchymal and CSF ROIs reported. Much work suggests the driving force for this PV transport is related to vessel pulsatility (Rennels et al. 1985; Hadaczek et al. 2006b; Iliff et al. 2013b) , with the result being a convective flow in the PVS (Cserr et al. 1977 Rennels et al. 1985; Ichimura et al. 1991; Ghersi-Egea et al. 1996a; Proescholdt et al. 2000; Abbott, 2004; Hadaczek et al. 2006b; Iliff et al. 2012 Iliff et al. , 2013a , although modelling has suggested transport processes other than bulk flow (e.g. dispersion as a result of local fluid motion) may also provide an explanation for fast PV tracer transport (Asgari et al. 2016) .
Our ex vivo fluorescence imaging results showed some degree of sdAb and IgG signal around vessels of all caliber (i.e. from arteries/arterioles to capillaries to venules/veins) and our in vivo MRI data for IgG were consistent with a net PV flow first appearing around the largest surface arteries (presumably the PV compartment) and later around cortical surface veins (e.g. the caudal rhinal vein). In vivo two-photon imaging has been used previously to show that CSF-infused fluorescent dextran conjugates appear first in PV compartments associated with arteries and then later in PV compartments associated with veins (Iliff et al. 2012) , suggesting a natural PV transport pathway traveling in the same direction as blood flow (Iliff et al. 2012 (Iliff et al. , 2013a Xie et al. 2013) , as proposed decades ago (Rennels et al. 1985) . It is worth noting that other studies have proposed that intramural PV transport (i.e. along the BM of arterial smooth muscle cells in the tunica media and possibly also along the capillary basal lamina) may occur in the opposite direction to flow under certain conditions Morris et al. 2016) . Further work is needed to confirm the direction of PV tracer transport in different vessels and their different compartments, as well as the mechanisms underlying such transport.
An important aspect of our results was the demonstration that both sdAb and IgG reached the PVS of microvessels (i.e. typical of capillaries, arbitrarily assigned as vessels with a lumen diameter less than 8 μm); whether convection may occur at these sites is unknown, partly because it is unclear whether a peri-capillary fluid space exists or if fused astrocyte and endothelial BMs result in a matrix compartment without an actual fluid space (Maynard et al. 1957; Jones, 1970; Cervós-Navarro & Ferszt, 1973; Peters et al. 1991) . Nevertheless, assuming flow in the PVS continues down to the region of exchange vessels such as capillaries, there are numerous possibilities for peri-capillary transport, such as diffusion and possibly also convection within either a fused BM or fluid space compartment. Whether peri-capillary convection is possible would in theory depend upon pressure gradients, porosity, viscosity and the dimensions of the space (Wolak & Thorne, 2013) ; further work is needed to explore likely possibilities. However, our results with both sdAb and IgG do confirm older studies (Wagner et al. 1974; Rennels et al. 1985) , as well as more recent studies (Jolly et al. 2011; Iliff et al. 2012) , reporting that macromolecule tracers infused into the CSF may distribute to a peri-capillary compartment. Peri-capillary transport after tracer infusion into the CSF is significant for at least two reasons: (i) it may be theoretically possible to access the PVS of all vessel types from the CSF, with the prospect of true global CNS delivery provided that there is sufficient diffusion into the neuropil from the peri-capillary region [neurons are rarely more than 10-20 μm from capillaries (Wolak & Thorne, 2013) , which is a short distance optimal for diffusion] and (ii) it may also be theoretically possible for circulation along the entire PV tree (e.g. from the PVS of arteries → arterioles → capillaries → venules → veins), as suggested previously (Rennels et al. 1985) , without requiring transport through the neuropil to reach peri-venous spaces (in contrast to a proposed convection through the neuropil as suggested in the 'glymphatic' concept (Iliff et al. 2012; Nedergaard, 2013) ). If such a directed circulation throughout the PV tree is indeed observed, it is unlikely that large molecules transported out of the brain from peri-venous compartments drain directly into the CSF. Many prior studies have demonstrated that labelled macromolecules [e.g. albumin or a poly(ethylene glycol)-dye conjugate] injected into the brain parenchyma drain primarily to cervical lymph nodes ipsilateral to the injection site (Bradbury et al. 1981; Szentistványi et al. 1984; Yamada et al. 1991; Aspelund et al. 2015) , whereas tracers applied to the CSF drain to cervical lymph nodes with no apparent lateralization (Bradbury et al. 1981) , as seen in the present study. These different drainage patterns may be important for mechanisms related to CNS immune privilege, as it has long been known that tissue grafts (and their associated antigens) generate far more potent immune responses when transplanted into CSF compartments than when transplanted into brain parenchyma (Engelhardt et al. 2017) .
We also observed a striking size-dependent access to PV pathways, with sdAb signal covering a four-to seven-fold greater percentage of slice area compared to IgG at each slice location analysed. Averaging values over the entire rostral-caudal distance sampled (Table 2) , we obtained approximate mean percentage areas accessed of 11.6% and 1.95% for sdAb and IgG, respectively. Size-dependent access for intracisternally infused dextran tracers has been noted previously in mice (Iliff et al. 2012; Lee et al. 2015; Peng et al. 2016) and rats (Iliff et al. 2013a) , although the reported percentage mean areas accessed have markedly varied across different studies by this group for unknown reasons [e.g. from ß5% to 50% (Iliff et al. 2012) for 3 kDa dextran in mice] so comparisons with the values reported in the present study may not be meaningful. One of the most striking differences we observed between sdAb and IgG concerned the prominent disposition of sdAb (but not IgG) in the smooth muscle BM of the tunica media in leptomeningeal arteries, as shown by confocal imaging of the vessel wall . Such an apparent size-dependent access to the tunica media compartment following intrathecal infusions has, to our knowledge, not been identified previously, although it has been noted that 15 nm gold nanoparticles do not access the BM between smooth muscle cells (Morris et al. 2016) . Coupling the (i) greatly reduced IgG access to the smooth muscle BM of large leptomeningeal arteries relative to sdAb with (ii) significant peri-capillary access for both sdAb and IgG suggests the existence of a low-resistance peri-capillary compartment that may not easily distinguish sdAb and IgG based on size, as expected for a peri-capillary fluid space in vivo rather than a fused astrocyte/endothelial BM compartment (Maynard et al. 1957; Jones, 1970; Cervós-Navarro & Ferszt, 1973; Peters et al. 1991) .
The unique pattern of PV signal associated with intrathecal sdAb and IgG across the rostral-caudal neural axis (Fig. 8) is likely dependent in some complex way on specific vessel branching patterns, continuity, pulsatility and regional variations in PV hydraulic conductivity (i.e. the pattern of PV signal probably depends on characteristics of the blood vessels that supply and drain specific CNS regions). The cerebrovascular architecture of rat surface arteries and their associated PVS has been described recently (Lochhead et al. 2015) , based on multiple sources (Scremin, 2004; Hammarlund-Udenaes et al. 2014) , and can be divided into an anterior circulation (principally the internal carotid and the anterior and middle cerebral arteries, along with their associated branches) and a posterior circulation (principally, the vertebral arteries, basilar artery and the posterior cerebral arteries, along with their associated branches). The olfactory bulbs and tracts consistently exhibited high PV signal in all animals, suggesting robust PV access and distribution associated with their arterial supply olfactofrontal and ventral olfactory J Physiol 596.3 arteries, all principally branching from the anterior cerebral artery) (Lochhead et al. 2015) ; other ventromedial brain regions (e.g. the septal nucleus and striatum) supplied by the anterior cerebral artery also exhibited consistently high PV signal, whereas dorsomedial territories exhibited somewhat variable PV signal. Striatal and ventrolateral cortical regions associated with the middle cerebral artery exhibited consistently high PV signal, whereas dorsolateral territories exhibited more variable PV signal. In general, ventral brain areas associated with proximal branches of posterior circulation vessels such as the diencephalon, midbrain and hindbrain exhibited consistently high PV signal (e.g. hypothalamus, a small portion of the ventromedial thalamus, and ventromedial midbrain supplied by thalamo-perforating and median mesencephalic branches of the posterior cerebral/basilar arteries), whereas areas supplied by more distal branches exhibited little or no PV signal (e.g. anterior/dorsal thalamus and anterior/dorsal hippocampus; e.g. 2.5 mm posterior to bregma). The very sparse PV signal in parts of the brainstem and cerebellar cortex was unexpected given that these areas are supplied by branches of the vertebral and basilar arteries, which were nearest to the infusion site and exhibited the highest PV signal on the brain surface. Taken together, the overall pattern of PV signal distribution was most prominent at ventral sites nearest the origin of arterial branches and less prominent at more distal sites. Furthermore, mannitol co-infused with IgG resulted in a somewhat global PV signal increase compared to that of IgG alone (i.e. PV signal was increased across many different areas supplied by both the anterior and posterior circulations).
Enhanced perivascular access of IgG with co-infusion of mannitol
Previous studies have demonstrated intrathecal infusions of hypertonic mannitol solutions to be reasonably well tolerated in animals (Speck et al. 1988) and 5% (0.27 M) sorbitol (an isomer of mannitol and a glucose metabolite) has been routinely used as a stabilizing excipient for viral gene therapy vectors intended for cisternal infusion (Samaranch et al. 2013) . However, our results represent the first characterization of the effects and possible mechanisms of intrathecally co-infused osmolytes on macromolecule distribution in the central compartment. We used ex vivo fluorescence imaging to evaluate intrathecal co-infusion of IgG with mannitol at two different mannitol concentrations (0.27 and 0.75 M), revealing a mannitol concentration-dependent increase in IgG signal for both the percentage brain area accessed and PV counts per mm 2 slice area. Interestingly, fluorescence intensity brain surface gradients did not appear to be affected by infusion of mannitol into the CSF at either concentration (Fig. 8) , suggesting that parenchymal diffusion was not enhanced by CSF mannitol and that the major contribution to increased IgG signal in brain probably originated from a local effect on CSF-facing lining cells of leptomeningeal vessels (and possibly also pial cells) resulting in increased PV access.
Intrathecal mannitol infusions were well-tolerated in our experiments. Hyperosmolar mannitol has been used in previous studies to modify BBB permeability characteristics (Rapoport et al. 1980; Neuwelt et al. 1982; Cserr et al. 1987) , but there has been little guidance on how intrathecal mannitol may impact the BBB or blood-CSF barriers. We expect that our intrathecal paradigm with 0.27 and 0.75 M mannitol minimally affected CNS barriers because (i) end-point (30 min post-infusion) plasma IgG levels were unaffected by 0.27 M mannitol and minimally affected by 0.75 M mannitol, consistent with mannitol not altering central IgG clearance to the systemic compartment; (ii) we employed a slow intrathecal infusion that probably subjected mannitol to continuous dilution as a result of CSF production and clearance; and (iii) extrapolation suggests the CSF mannitol levels likely to have resulted from our infusions were well below levels associated with BBB modulation with systemically applied mannitol. Even if intrathecal mannitol had been administered as a bolus rather than a slow infusion over 50 min, we estimate that it would have been diluted approximately three-fold in the CSF (considering a bolus 80 μL volume of 0.75 M mannitol infused into ß250 μL of total subarachnoid CSF; total CSF volumes in the rat range ß150-300 μL; Davson & Segal, 1995; Fenstermacher et al. 1999; Preston, 2001) . Such a dilution would have resulted in a concentration of ß0.24 M mannitol assuming instantaneous mixing. The threshold for increasing BBB permeability with systemic mannitol has been reported to necessitate mannitol dosing resulting in blood concentrations (assuming rats weighing 250 g with a blood volume of ß13 mL; Everett et al. 1956 ) of ß0.39-0.57 M mannitol (Rapoport et al. 1980; Neuwelt et al. 1982; Cserr et al. 1987) . Previous work has also shown a fairly short time window of increased BBB permeability in rats (ß1 h) with systemic mannitol application (Rapoport et al. 1980) . We therefore expect the effects of intrathecal mannitol to be temporary and reversible. Nevertheless, additional studies aiming to investigate the kinetics and full range of actions for intrathecal mannitol infusions are warranted.
Periventricular white matter signal
Interestingly, animals infused with the smaller sdAb or, to a lesser extent, with IgG exhibited diffuse antibody signal in periventricular white matter areas surrounding the LVs (e.g. corpus callosum, external capsule, deep cerebral white matter) and extending rostrally into the olfactory ventricles (Fig. 8) . Ex vivo fluorescence after sdAb infusion demonstrated this periventricular white matter signal in all animals. Infusion of IgG revealed a substantially smaller area of spread in four of six animals. Co-infusion of 0.27 M mannitol did not show apparent differences from IgG alone (signal present in three of six animals), but co-infusion of 0.75 M mannitol resulted in substantial diffuse IgG signal in periventricular white matter in eight of nine animals, although the spread was still less than for sdAb. The precise origin of this periventricular signal is at present not clear and will require further study. Multiple findings suggest that backflow from the cisterna magna into the ventricular compartment (i.e. from cisterna magna → fourth ventricle (4V) via foramina of Luschka and Magendie → third ventricle (3V) via cerebral aqueduct of Sylvius → LVs via intraventricular foramina of Monro) did not account for periventricular signal in our experiments. First, our infusion rate of 1.6 μl min −1 has been demonstrated by others to be below the rate (ß3 μl min −1 ) at which an infusion-dependent acute elevation in intracranial pressure first occurs in the rat (Yang et al. 2013; Bedussi et al. 2017) ; such an elevation, were it to occur, might in principle be accompanied by backflow from the subarachnoid space into the ventricles. Second, close examination of ex vivo fluorescence in coronal sections spanning across the brain (Fig. 8) revealed prominent periventricular signal in the LVs, with far less periventricular signal adjacent to the 3V and 4V; backflow would have been expected to produce the opposite gradient as a result of a dilution effect (i.e. with expected signal levels adjacent to the ventricles in the order of 4V > 3V > LVs). Third, MRI comparison of Gd-IgG signal associated with LV and 4V ROIs (Fig. 6G-I ) showed that our infusion paradigm did not result in signal change from baseline suggestive of backflow (i.e. where 4V changes would be expected to exceed and precede LV changes). Furthermore, the kinetics of percentage change from baseline in Gd-IgG contrast in LV and 4V ROIs resembled parenchymal ROIs rather than CSF ROIs from subarachnoid cisterns (compare Fig. 6I with Fig. 6E  and F) . Taken together, the results suggest that infused antibodies gained entry to tissue compartments adjacent to the LV and perhaps other ventricular compartments via other pathways.
We speculate that two pathways may have contributed to this observed periventricular signal: (i) spillover from PV compartments associated with the choroidal arteries and (ii) alternative cistern-to-ventricle flow paths associated with the LV choroidal fissure, velum interpositum and medullary velae. The former possibility is supported by the observation that the choroid plexus often exhibited fluorescence, particularly with sdAb infusions. Transport within the PVS of the posterior cerebral artery, which branches to provide anterior, posterior lateral and posterior medial choroidal arteries supplying the ventricular choroid plexuses that are most abundant within the LVs (Coyle, 1975) , may have resulted in some spillover in these regions, with subsequent flow along low resistance periventricular pathways associated with adjacent white matter or subependymal areas (Cserr et al. 1977; Szentistványi et al. 1984; Ichimura et al. 1991) . The latter possibility is suggested by several observations made in other studies in which direct connections have been inferred between the ventricular spaces and cisterns at specialized sites where the pia, ependyma and leptomeningeal vessels are in close proximity; such sites, revealed by labelled tracer infusions, may include the LV choroidal fissure (Bedussi et al. 2017) , the velum interpositum (Ghersi-Egea et al. 1996a ) and the superior medullary velum (Ghersi-Egea et al. 1996a) . Other studies employing low flow rate infusions in rats have also reported tracer signal in ventricular compartments such as the LV (Bedussi et al. 2017 ) and mesencephalic 4V (Iliff et al. 2013a) ; indeed, Benveniste and colleagues have reported size-dependent signal accumulation has been reported with two different cisternally-infused MRI contrast agents (938 Da Gd-DPTA >> 200 kDa GadoSpinP) at the cerebral aqueduct/4V (Iliff et al. 2013a ) using the same infusion rate as that in the present study.
Potential PVS access sites
Very little information exists from past rodent studies regarding the nature of the transport barrier(s) that might be responsible for the size-dependent PV access from the CSF (and its manipulation by mannitol) seen in the present study. Scanning EM studies in other species have indicated the presence of fenestration-like stomata between CSF-facing lining cells of leptomeningeal vessels in the subarachnoid space (Cloyd & Low, 1974; Zervas et al. 1982 ) with a potential role in supplying nutrients to large cerebral vessels that lack the vasa vasorum present elsewhere in the body (Zervas et al. 1982) , but the possibility that such pores exist in rodents has thus far only been suggested by isolated observations from two previous transmission electron microscopy studies (Frederickson & Low, 1969; Oda & Nakanishi, 1984) . In the present study, we used scanning EM to show the presence of numerous micron-sized stomata on leptomeningeal cells of subarachnoid vessels from both the anterior and posterior circulations in the rat. The general dimensions, circularity and dense underlying connective tissue of these stomata closely resemble leptomeningeal vessel fenestrations seen with scanning EM in the cat (Zervas et al. 1982) , as well as pial fenestrations that have been observed with scanning EM in dogs (Cloyd & Low, 1974) and humans (Reina et al. 2004) . We speculate that sieving by such structures (stomata and their closely associated connective tissue) may be responsible at least in part for the reduced PV J Physiol 596.3 access observed for the larger IgG relative to the smaller sdAb. Furthermore, our result showing that mannitol co-infusions significantly increased PV access of IgG appears to be consistent with an osmotic effect on stomata and/or intercellular gaps between leptomeningeal vessel lining cells (or pial cells). More work is needed to investigate such structures, their regional distribution and their possible modulation.
Involvement of the olfactory clearance route for CNS antibody drainage
Drainage of CSF-or parenchymally-administered tracer substances along olfactory nerves to the nasal mucosa and then to the cervical lymph nodes has been suggested in many prior studies Koh et al. 2005) , mostly using tracers such as India ink (Kida et al. 1993) , radiocontrast (Faber, 1937) or radiolabelled substances (Bradbury & Westrop, 1983) , but this communication route has recently been questioned (Louveau et al. 2015) . In the present study, using ex vivo fluorescence and confocal imaging, we have shown that intrathecal infusions of sdAb and IgG resulted in (i) prominent signal in the nasal mucosa, predominantly associated with the olfactory region; (ii) IgG signal throughout the olfactory lamina propria; and (iii) prominent signal in the deep cervical lymph nodes. Confocal imaging of the olfactory mucosa demonstrated IgG associated with connective tissue and numerous vessels throughout the lamina propria (Fig. 12E-I ), in proximity to areas shown by scanning EM to contain lymphatics (Furukawa et al. 2008) , and ex vivo fluorescence imaging of olfactory bulb sections showed sdAb and IgG throughout the olfactory nerve layer. These results are consistent with IgG clearance/drainage along olfactory PV/perineural spaces and/or lymphatics across the cribriform plate to the olfactory mucosa, as demonstrated in other studies using different tracers (Faber, 1937; Kida et al. 1995; Koh et al. 2005; Aspelund et al. 2015) . Preferential drainage of sdAb and IgG to the olfactory region (with much less drainage to the nasal respiratory mucosa) may be functionally important because the olfactory mucosa exhibits significantly lower relative vascularity and vascular permeability, that have been speculated to favour lymphatic drainage from the olfactory lamina propria to regional lymph nodes (e.g. deep cervical) (Kumar et al. 2016) . Antibody signal was also evident in proximity to several cranial and spinal nerves, some of which appeared to be in the ensheathing dura, possibly associated with dural lymphatics (Aspelund et al. 2015) ; dissection and imaging of dorsal cranial dura revealed intrathecally infused IgG signal localized around sinuses, a portion of which may have been associated with dural lymphatics (Aspelund et al. 2015; Louveau et al. 2015) .
Significance for CNS physiology, pathology and drug delivery
Endogenous IgG antibodies are the second most abundant proteins in CSF (after albumin), representing ß7-12% of total CSF protein (Davson & Segal, 1995) , yet surprisingly little is known about their precise distribution pathways from the CSF into the brain; indeed, the nature and limits of the PV pathways taken by endogenous antibodies as they traffic into the brain may have significant implications for immune surveillance (Schmitt et al. 2012) . We have shown that CSF-borne IgG (10 nm d H ) has difficulty in accessing the BM between smooth muscle cells, whereas the smaller sdAb (4.5 nm d H ) appears to penetrate the tunica media compartment fully. We speculate that a smaller protein than sdAb (e.g. the soluble 40-residue form of β-amyloid) (Aβ 1-40 ), might also be expected to also easily access the BM compartment between smooth muscle cells from the CSF and, once there, to remain relatively hidden from PV circulating IgG (endogenous or exogenous) originating from the CSF. Indeed, other studies have speculated that cerebrovascular amyloid in Alzheimer's disease, characterized in large part by Aβ 1-40 deposition in the BM between smooth muscle cells, may originate from CSF Aβ 1-40 (Ghersi-Egea et al. 1996b) ; interestingly, such amyloid deposition has proven difficult to clear by either systemic or centrally administered antibody (Koenigsknecht-Talboo et al. 2008) . We speculate that the PV trafficking of IgG and other proteins may have unique relevance for cerebral amyloid angiopathy , autoimmune disease (Asgari et al. 2015) and other conditions where IgG surveillance pathways between the CSF and parenchyma may affect pathogenesis. Stomata on leptomeningeal lining cells of subarachnoid vessels may also provide unique pathways for the trafficking of immune cells (Merchant & Low, 1977) . The results of the present study also reaffirm the importance of olfactory drainage pathways for CSF clearance, with previously described potential implications for central antigen drainage (Bradbury & Westrop, 1983; Kida et al. 1993; Knopf et al. 1995; Engelhardt et al. 2017) . Finally, our results may have unique relevance for understanding, optimizing and translating several CNS drug delivery approaches, particularly the central infusion of antibodies and other proteins by the intrathecal and/or intraventricular routes, because they emphasize the critical importance of PV pathways in achieving more extensive central distribution. In agreement with much previous work (Fenstermacher & Patlak, 1976; Thorne et al. 2004; Thorne & Nicholson, 2006; Syková & Nicholson, 2008; Wolak & Thorne, 2013) , our results confirm that brain surface gradients of sdAb and IgG are consistent with diffusive transport into the brain from the CSF; from this result, we infer that transport through the neuropil of the grey matter adjacent to the PV pathways is also probably diffusive in nature under normal conditions. Importantly, gradients produced by diffusion are not expected to scale with increasing brain size (Wolak & Thorne, 2013; Wolak et al. 2015) , whereas it is increasingly probable that circulation/distribution of CSF and ISF within the ventricles, extraventricular sites and the PVS do represent scalable phenomena (Rennels et al. 1985; Jolly et al. 2011; Samaranch et al. 2013) . Our results may ultimately prove extrapolatable to accurately predict central distributions for other intrathecally infused macromolecules of similar size, although we would caution that differences in physicochemical characteristics (e.g. charge and conformational flexibility), binding capacity (e.g. to endogenous receptors and/or extracellular matrix constituents; Thorne et al. 2008) and the CNS environment itself (e.g. disease effects) may reasonably be expected to change distributions subtly or dramatically depending on the circumstances; in the end, different classes of macromolecules and other biologics will need to be carefully studied for such changes to become evident. Taken together, the significance of these findings for central drug delivery is that access to and distribution within PV pathways may ultimately dictate the success or failure of a variety of different approaches [e.g. intranasal (Lochhead et al. 2015) , intrathecal or intraventricular administration] aimed at whole brain delivery. Understanding the key physiological determinants of central distribution may allow optimization strategies (e.g. the use of smaller active drug fragments or osmolyte co-infusion, as we described here) to enhance the prospects for success in translating pre-clinical CNS drug delivery studies to the clinic. 
Translational perspective
Mechanistic understanding of methods for traversing or bypassing the barriers between the blood and the central nervous system (CNS) in order to achieve effective delivery of biologics (e.g. peptides, proteins, oligonucleotides and gene therapies) to the brain and spinal cord has been a major challenge in biomedical research. The past several decades have witnessed many preclinical and clinical trials aimed at demonstrating efficacy for biologics in the treatment of CNS disorders but successful translation to the clinic has been rare; although most such trials have centred around strategies attempting to deliver a biologic or conjugate across the blood-brain barrier, currently, there are only three examples of clinically approved biologics (US and EU) that are unequivocally delivered to CNS target sites and each of these involves bypassing the CNS barriers with cerebrospinal fluid (CSF) infusions (intrathecal ziconotide, a peptide, for chronic pain; intrathecal nusinersen, an antisense oligonucleotide, for spinal muscular atrophy; intracerebroventricular cerliponase alfa, an enzyme replacement therapy, for a form of neuronal ceroid lipofuscinosis). However, detailed descriptions of the factors that govern the distribution of biologics, particularly therapeutically promising antibodies and antibody fragments, from the CSF to brain tissue have been surprisingly limited. Our findings clarify how the CSF to brain transfer of antibodies occurs in rats, showing the physiological and anatomical correlates that underlie intrathecal antibody delivery, as well as the trafficking of endogenous antibodies. Our results suggest that perivascular access and distribution of antibodies, and likely other biologics, has been underappreciated as a key physiological determinant of whether extensive central distribution is achievable with CSF infusions.
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Video S1. Background-subtracted 3D dynamic visualization of infused Gd-IgG signal with time (ventral view and 360°rotation).
Video S2. Background-subtracted 3D dynamic visualization of infused Gd-IgG signal with time (lateral view of left hemisphere).
